AbbVie Inc said on Tuesday that the U.S. Food and Drug Administration approved its Skyrizi drug as a treatment for plaque psoriasis at a time when its blockbuster psoriasis drug, Humira, faces patent pressures.
Original source: http://feeds.reuters.com/~r/reuters/INhealth/~3/Gk7LlEp-MtA/abbvies-skyrizi-drug-to-treat-psoriasis-wins-u-s-approval-idINKCN1RZ2LF